@FierceMedDev: Sequenom vows to appeal court decision invalidating prenatal test patent. More | Follow @FierceMedDev
@MarkHFierce: PerkinElmer said the government shutdown could, in part, affect revenue projections for the year. ICYMI yesterday | Follow @MarkHFierce
@MichaelGFierce: OptiNose starts PhIII inhaler study for nasal polyps. Article | Follow @MichaelGFierce
> Robotic surgical systems are causing problems, but issues are either reported late to the FDA, inaccurately or not at all, a new study concluded. Story
> Biomet said it has closed its acquisition of Lanx, a venture-backed maker of FDA-cleared spin fusion systems. Item
> Moog ($MOG.A) reported $15.6 million in fourth quarter earnings, down from $41.8 million last year, due to impairment charges on medical devices and restructuring. Story
> Nuance Communication plans to launch new technology for doctors that will turn mobile phones into virtual assistants that understand clinical language. Story
> Silex Medical, a maker of laparoscopic surgical instruments, will be both hurt and helped by the Affordable Care Act. Story
Biotech News
@FierceBiotech: Popular yesterday: Feds launch probe of AstraZeneca's controversial late-stage Brilinta study. Article | Follow @FierceBiotech
@JohnCFierce: NovaQuest lands $459M fund for goal-line dealmaking--That's $1.2B for today. More | Follow @JohnCFierce
@DamianFierce: GlobeImmune pulls plug on $75M IPO despite still-bubbling market. Article | Follow @DamianFierce
@EmilyMFierce: Scripps Research scientists reach major milestone w/ HIV research, paving wave for new vaccine efforts. FierceBiotech Research story | Follow @EmilyMFierce
> Flailing Ariad swallows poison pill to fend off takeovers. More
> VC OrbiMed hauls in $735M fund in 'vibrant' time for biotech. News
> NovaQuest lands $459M fund for goal-line dealmaking. Story
Pharma News
@FiercePharma: Thursday's top story: Novo Nordisk recruiting 400 U.S. sales reps as growth decelerates. Article | Follow @FiercePharma
@EricPFierce: FDA has new plan to arrest drug shortages. Its ultimate solution is for drugmakers to improve quality. Story | Follow @EricPFierce
@CarlyHFierce: Once again, Bayer's new drugs power pharma sales upward. ICYMI yesterday | Follow @CarlyHFierce
> Mylan looks to 2014 for big growth. Report
> Teva says it may have violated bribery laws around the world. More
> Vertex's Incivek unseats Celebrex as fastest drug launch ever. Story